Oktober 2021: Uprava za hrano in zdravila je odobrila kabozantinib (Cabometyx, Exelixis, Inc.) za odrasle in pediatrične bolnike, stare 12 let in več, ki imajo lokalno napredovalo ali metastatsko diferencirano ščitnico.
Lenvatinib (Lenvima) New oral anticancer drug Lenvima (lenvatinib) has recently been approved by Japan for the treatment of unresectable thyroid cancer. This is another important market that the drug has captured since it was app..